HeartBeam (BEAT) Cash & Equivalents (2022 - 2026)

HeartBeam (BEAT) has 5 years of Cash & Equivalents data on file, last reported at $600000.0 in Q1 2026.

• On a quarterly basis, Cash & Equivalents fell 86.33% year-over-year to $600000.0 in Q1 2026; TTM through Mar 2026 was $600000.0, a 86.33% decrease from a year earlier, with the FY2025 full-year figure at $4.4 million, up 84.27% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $600000.0, down from $4.4 million in the prior quarter.
• Over the last five years, Cash & Equivalents for BEAT reached as high as $19.2 million in Q3 2023 and fell as low as $600000.0 in Q1 2026.
• Historically, Cash & Equivalents has averaged $7.3 million across 5 years, with a median of $5.1 million in 2024.
• Across the five-year window, Cash & Equivalents jumped 1176.57% in 2024 and slumped 86.33% in 2026, its largest moves.
• Year by year, Cash & Equivalents stood at $2.6 million in 2022, then soared by 511.54% to $15.9 million in 2023, then slumped by 85.05% to $2.4 million in 2024, then surged by 84.27% to $4.4 million in 2025, then slumped by 86.3% to $600000.0 in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $600000.0 in Q1 2026, $4.4 million in Q4 2025, and $1.9 million in Q3 2025.